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Three-Dimensional Solution Structure of Human
Interleukin-4 by Multidimensional Heteronuclear
Magnetic Resonance Spectroscopy
Robert Powers, Daniel S. Garrett, Carl J. March, Eric A. Frieden,
Angela M. Gronenborn, G. Marius Clore *
The three-dimensional solution structure of recombinant human interleukin-4, a protein of
133 residues and 15.4 kilodaltons that plays a key role in the immune and inflammatory
systems, has been solved by multidimensional heteronuclear magnetic resonance spectroscopy. The structure is dominated by a left-handed four-helix bundle with an unusual
topology comprising two overhand connections. The linker elements between the helices
are formed by either long loops, small helical turns, or short strands. The overall topology is remarkably similar to that of growth hormone and granulocyte-macrophage colony
stimulating factor, despite the absence of any sequence homology, and substantial differences in the relative lengths of the helices, the length and nature of the various connecting elements, and the pattern of disulfide bridges. These three proteins, however, bind to
cell surface receptors belonging to the same hematopoietic superfamily, which suggests
that interleukin-4 may interact with its receptor in an analogous manner to that observed
in the crystal structure of the growth hormone-extracellular receptor complex.

I

nterleukin-4 (IL-4) is one of a group of cytokines that play a central role in the control and regulation of the immune and inflammatory systems (1). Specific activities associated with IL-4
are the stimulation of activated B cell, T lymphocyte, thymocyte, and mast cell proliferation and
the induction of cytotoxic CD8+ T cells. The latter is responsible for the antitumor activity of IL4. Renal tumor cells that secrete large doses of IL-4 can establish tumor-specific immunity toward a preexisting renal cancer (2). In addition, IL-4 induces the expression of class II major histocompatibility complex (MHC) molecules and the immunoglobulin E (IgE) low-affinity receptor
on resting B cells (3). Further, IL-4 is responsible for generating and sustaining in vivo IgE responses and for ensuring the dominance of IgG1 in the T cell-dependent immune response by
causing immunoglobulin class switching of activated B cells to IgE and IgG1, respectively (3). In
order to provide a structural basis for understandine the mode of action of IL-4 and its interaction
with its cell surface receptor, we have determined the three-dimensional (3D) structure of human
recombinant IL-4 (15.4 kD and 133 residues) in solution using multidimensional heteronuclear
NMR (nuclear magnetic resonance) spectroscopy.
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The NMR structure determination was principally based on 823 approximate interproton distance restraints derived from 3D 15N- (4) and 13C-separated (5) NOESY (nuclear Overhauser
enhancement spectroscopy) spectra and a 1H-15N HMQC (heteronuclear multiple quantum coherence)–NOESY-HMQC spectrum (6) recorded on uniformly (>95%) labeled 15N and 13C-15N–
labeled human recombinant IL-4 (7, 8). These spectra were interpreted on the basis of complete
1H, 15N, and 13C assignments obtained previously with 3D double- and triple-resonance NMR
spectroscopy (9). [Note that a partial set of 1H and 15N assignments has also been published by
Redfield et al. (10)]. An example of the quality of the 3D 13C-separated NOESY spectrum is
shown in Fig. 1. The interproton distance restraints were classified into three distance ranges, 1.8
to 2.7 Å, 1.8 to 3.3 Å [1.8 to 3.5 Å for nuclear Overhauser effects (NOEs) involving NH protons], and 1.8 to 5.0 Å, corresponding to strong, medium, and weak NOEs, respectively (11, 12).
With the exception of sequential CβH(i)-NH(i+1) NOEs, all NOEs involving side chains were
derived from the 3D 13C -separated NOESY spectrum. Although the 1H chemical shift dispersion of IL-4 is small (10), the increased resolution afforded by separating the NOEs into a third
dimension according to the 13C chemical shift of the carbon atom attached to the destination proton is sufficient to extract a large number of NOEs unambiguously by making use of the symme-

Fig. 1. Example of a 1H(F1)- 1H(F3) plane taken at 13C(F2) = 53.35 ± 20.71 n ppm (where n
is an integer) of the 100-ms mixing time 3D 13C-separated NOESY spectrum of uniformly
(>95%) 15N-13C labeled recombinant human IL-4. A number of long-range NOEs to the
CδH3 methyl group of IleI5 and CγH protons of Met124 are indicated. Positive and negative
contours (arising as a result of the extensive folding used in the 13C dimension) are indicated by solid and dashed lines, respectively.
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try relations inherent to this spectrum. Thus, the NOE from proton i to proton j is labeled by the
13C chemical shift of the carbon atom attached to proton j, and the symmetry-related NOE from
proton j to proton i is labeled by the 13C chemical shift of the carbon atom attached to proton i.
In this manner, we readily assigned a large number of interresidue side chain-backbone and side
chain-side chain NOE interactions that comprised 188 and 205 restraints, respectively (Fig. 2).
The interproton distance restraints were supplemented by 101 φ torsion angle restraints derived
from 3JHNα coupling constants (13), 82 ψ torsion angle restraints within clearly defined helical regions derived from 13Cα and 13Cβ chemical shifts (14), and, subsequent to preliminary structure
calculations, 98 distance restraints for 49 backbone NH–CO hydrogen bonds derived from slowly
exchanging backbone amide resonances (15) and the pattern of medium-range (1 < |i – j| ≤ 5) and
interstrand backbone-backbone NOES within the helical and β-sheet regions, respectively (16).
There are a total of 1104 experimental NMR restraints. At present no stereospecific assignments
of β-methylene protons and methyl groups of Leu and Val have been obtained. Also, the structure
calculations do not include any χ1 torsion angle restraints. Hence the present structure should be
regarded as a good-quality second-generation structure (17).

Fig. 2. Summary of the NOE connectivities assigned in the 3D heteronuclear spectra of
recombinant human IL-4. Side chain-side chain NOEs (♦) are shown above the diagonal
and side-chain-backbone (▲) and backbone-backbone (●) NOEs are below the diagonal.
The location of the four long helices comprising the four-helix bundle and the two strands
is indicated below the figure.
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A total of 22 simulated annealing (SA) structures (18) were calculated with the hybrid-distance geometry-simulated annealing protocol of Nilges et al. (19, 20) (Table 1). All of the structures satisfy the NMR restraints within experimental error (that is, no violations greater than 0.5
Å and 5º for the distance and torsion angle restraints, respectively), exhibit very small deviations
from idealized covalent geometry, and display good nonbonded contacts as judged by the large
negative values of the calculated Lennard-Jones van der Waals energy (21) and the solvation free
energy of folding (22). A best-fit superposition of the 22 SA structures is shown in Fig. 3A. Residues 1 to 6, 132, and 133 are disordered; only residues 6 to 132 are shown in Fig. 3. The atomic
root-mean-square (rms) distribution about the mean coordinate positions for residues 7 to 13 l is
1.02 ± 0.16 Å for the backbone atoms and 1.50 ± 0.17 Å for all atoms; the corresponding rms values for the regions of secondary structure (residues 7 to 24, 26 to 36, 45 to 64, 67 to 70, 74 to 96,
and 107 to 129) are 0.79 ± 0.13 and 1.25 ± 0.27 Å, respectively (23).

Table 1. Structural statistics. The notation of the structures is as follows ‚SAÚ are the 22 SA structures; SA is
the mean structure obtained by averaging the coordinates of the individual SA structures best fitted to each
other (the residues used in the best fitting are 7 to 131); and (S̄Ā)r is the restrained minimized (regularized)
mean structure obtained from SA. The number of terms for the various restraints are given in parentheses;
rms, root-mean-square; and expt, experimental.
Parameter
Rms deviations from expt distance restraints (Å)*
All (921)
Sequential ( | i – j | = 1) (283)
Medium range (1 < | i – j | ≤ 5) (305)
Long range ( | i – j | > 5) (235)
Hydrogen-bond restraints (98) †
Rms deviation from expt torsion
Angle restraints (degrees) (183) ‡
Deviations from idealized covalent geometry §
Bonds (Å) (2175)
Angles (degrees) (3929)
lmpropers (degrees) (835)
EL–J (kcal mol–1) ║
SFE (kcal/mol–1) ¶

‚SAÚ
0.033 ±
0.033 ±
0.034 ±
0.033 ±
0.029 ±

0.005
0.004
0.007
0.010
0.006

0.293 ± 0 088
0.002 ± 0.0003
0.362 ± 0.040
0.346 ± 0.053
-410
± 10
-139
± 3

(S̄Ā)r
0.031
0.028
0.029
0.039
0.023
0.288
0.002
0.327
0.297
- 396
-149

* None of the structures exhibit distance violations greater than 0.5 Å or dihedral-angle violations greater than
5°. No intraresidue interproton distance restraints were used in the calculations The medium-range NOEs
comprise 140 backbone-backbone; 113 side chain-backbone, and 52 side chain-side chain NOEs, and
the long-range NOES comprise 7 backbone-backbone, 75 side chain-backbone. and 153 side chain-sidechain NOEs.
† Each hydrogen bond is characterized by two distance restraints: rNH–O ≤ 2.3 Å and rNH–O = 2.5 to 3.3 Å. All
hydrogen-bonding restraints include slowly exchanging backbone amide protons.
‡ There are 101 Φ and 82 ψ backbone torsion angle restraints (13, 14).
§ The Improper torsion restraints serve to maintain planarity and chirality.
║ EL–J is the Lennard-Jones van der Waals energy calculated with the CHARMM (21) empirical energy function and is not included in the target function for simulated annealing or restrained minimization
¶ SFE is the calculated solvation free energy of folding (22) and is not included in the target function for simulated annealing or minimization. The expected value of the SFE for a protein the size of human recombinant IL-4 (133 residues) is –135 kcal mol–1 (22).
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Fig. 3. (A) Stereoview of the best-fit superposition of the backbone (N, Cα, and C) atoms of the 22 SA structures (red) of recombinant human IL-4. Only residues 6 to 132 are
shown as the amino and carboxyl termini are disordered, and the native sequence starts
at residue 5. The restrained minimized mean (S̄Ā)r structure is shown in yellow to guide
the eye. (B) Stereoview of the restrained minimized mean (S̄Ā)r structure illustrating the
hydrophobic packing within the core of the protein. The backbone is shown in blue, the
three disulfide bridges (Cys7-Cys131, Cys28-Cys69, and Cys50-Cys103) in yellow, the hydrophobic residues within the core of the four-helix bundle in red, and the residues involved in
hydrophobic interactions between the two strands and helices αB and αD, in orange.
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The IL-4 molecule is oblong in shape with approximate dimensions of 41 Å by 28 Å by 19 Å.
The major topological feature is a left-handed four-helix bundle with an unusual connectivity in
which helices adjacent to each other on a square lattice are antiparallel, whereas nonadjacent opposing helices are parallel. Thus the bundle has two overhand connections (Fig. 4). The angles
and axial separations between the long axes of the four antiparallel helical pairs, αA-αC, αC-αB,
αB-αB and αD-αA, are –153º and 9.0 Å, –148 º and 5.9 Å, –142º and 10.3 Å, and –154º and 9.1 Å,
respectively. The corresponding values between the two parallel helical pairs, αA-αB, and αC-αD,
are 42º and 11.9 Å, and 45º and 13.8 Å, respectively. The four helices have approximately similar lengths and comprise residues 7 to 24 (αA), 45 to 64 (αB), 74 to 96 (αC), and 113 to 129 (αD).
The connecting elements between the helices are formed by either long loops, small helical turns,
or short strands. Specifically, helix αA leads into a five-residue helical turn (htA, residues 26 to
30) followed by a strand (βA, residues 3 1 to 36) that runs in an antiparallel direction to helix αA
and a loop (residues 37 to 44) that leads into helix αB. Helices αB and αC are connected by a short
loop (residues 65 to 73) that contains a short four-residue helical turn (htB, residues 67 to 70). The

Fig. 4. Ribbon drawing of the restrained minimized mean (S̄Ā)r structure of recombinant
human IL-4. Residues 6 to 131 are shown. The four helices (αA, αB, αC, and αD) comprising the left-handed four-helix bundle are shown in red, the two small helical turns (htA and
htB) in green, the two short strands (βA and βB) in blue, and the three disulfide bridges in
yellow. The model was generated with the program Ribbon 2.0 (32).
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two helical turns, htA and htB, are connected to each other by a disulfide bridge between Cys28
and Cys69. Helix αC leads into a loop (residues 97 to 106) and a short strand (βB, residues 107 to
112) that runs antiparallel to αC and leads directly into the fourth helix αD. The loop from residues
97 to 106 is connected to helix αB through a disulfide bridge between Cys103 and Cys50. The two
strands form a mini-antiparallel β sheet comprising residues 32 to 34 of βA and 110 to 112 of βB.
Finally, the amino terminus of helix αA and the carboxyl-terminal end of IL-4 are connected by
the disulfide bridge between Cys7 and Cys131.
The internal core of the four-helix bundle is entirely hydrophobic in nature and consists of
Leu11, Ile14, Leu18, and Leu21 of αA, Phe49, Ala52, Led56, Phe59, and Tyr60 of αB, Ile84, Leu87, Leu90,
Leu94, and Leu97 of αC, and Leu113, Leu117, Leu120, Met124, and Tyr128 of αD. The packing within
the hydrophobic core is shown in Fig. 3B. In addition, there are also a number of hydrophobic interactions between βA (Thr34 and Ile34) and αB (Val55 and Ala52), βA (Val33, Ile36, and Phe37) and
αD (Leu113, Phe116, Leu120, and Ile123), and βA (Thr34) and βB (Ala108) (Fig. 3B). Turns htA and htB
are in part stabilized by side chain-backbone hydrogen bonds such as the one between Thr29 OγH
and the backbone CO of Lys25, and the one between the side chain carboxylate of Asp66 and the
backbone NH of Cys69, respectively. The exterior of IL-4, on the other hand, is hydrophilic and
contains a large number of positively charged Lys and Arg residues.
To our knowledge, the topology of the left-handed four-helix bundle seen in IL-4 has only
been observed twice previously, namely, in the cases of growth hormone (24, 25) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (26). Although the relative orientations of
the four helices comprising the bundle are similar for the three proteins, the structural details are
quite distinct, both with regard to the relative lengths of the helices and the length and nature of
the various connecting elements. Thus, in the case of growth hormone, helices αA (26 residues)
and αD (30 residues) are substantially longer than helices αB (21 residues) and αC (23 residues),
whereas in the case of IL-4 the reverse is true with αA (18 residues) and αD (17 residues) being
shorter than αB (20 residues) and αC (23 residues). In GM-CSF, on the other hand, all four helices are significantly shorter and have lengths ranging from 10 residues for αD to 16 for αA, with
the other two helices comprising 14 residues each. These differences result in a distinct alteration
in the surface at the top of the front face of the three proteins in the view shown in Fig. 4. In addition, the pattern as well as the number of disulfide linkages (two in growth hormone and GMCSF versus three in IL-4) is different. Finally, there is no sequence similarity between the three
proteins.
Nevertheless the overall resemblance between the topologies of IL-4, GM-CSF, and growth
hormone is striking given the lack of sequence, disulfide bond, and length similarity. On the other
hand, the receptors for these three proteins belong to the same hematopoietic superfamily, which
also includes the receptors for interleukins-2, -3, -5, -6, and -7, granulocyte colony stimulating
factor, erythropoietin, prolactin, leukemia inhibitory factor, and ciliary neutrophic factor (27). The
interaction of IL-4 with the extracellular domain of its receptor may be similar to that observed
in the crystal structure of the growth hormone–extracellular receptor complex (25), in which case
IL-4 would interact with the extracellular domains of two receptor molecules and the site of interaction with one receptor would involve the surface formed by helices αA and αC, while the other
interaction site would involve the surface formed by helix αD, strand βA, and the loop connecting
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βA to helix αB. The first site is located at the right-hand lower edge of the molecule in the view
shown in Fig. 4 and is made up of Lys6, Glu13, Lys16, Ser20, Gln82, Arg85, Arg89, and Asn93. The
second site is located on the left side of the molecule in the view shown in Fig. 4 and comprises
Asp35, Asp42, Glu45, Asn115, Arg119, G1u126, and Lys127. Despite the high degree (~44%) of overall sequence identity between human and mouse IL-4 (28), only 5 (Glu13, Asp42, Glu45, Arg85, and
Arg89) of the 15 residues proposed to interact with the receptor are conserved, and the substitutions involve either charge removal (for example, Lys6 → Gly, Lys16 → Gly, Asp35 → Asn, Arg119
→ Ser, and G1u126 → Met) or charge reversal (Ser20 → Glu, Glu82 → Arg, and Lys127 → Asp).
In addition, sequence alignments between the human and mouse IL-4 sequences result in a gap in
the mouse sequence relative to the human one either at the beginning (28) or end of helix αC (29),
and therefore probably constitutes the region with the largest conformational differences between
the human and mouse protein. This difference may account for the observation that human and
mouse IL-4 do not exhibit cross-species activity with regard to either receptor binding or biological function (30, 31).
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